Updates

CONTACT US

July 23, 2024

Glenmark Drug Recall: Potassium Chloride Extended Release Capsules

On June 24, 2024, the FDA published a recall of certain batches of Glenmark Pharmaceuticals’ Potassium Chloride Extended Release Capsules because they failed to meet the…

View Details

July 17, 2024

Understanding Class Action Lawsuits: What You Need to Know

If you’ve ever heard about class action lawsuits but weren’t quite sure what they entailed, you’re not alone. These legal actions can seem complex, but…

View Details

July 8, 2024

Victory for Main Street Burger in Lease Renewal Dispute

The Block Firm is thrilled to announce a significant legal victory for our client, Main Street Burger, Inc., in their recent appellate case against the…

View Details

July 1, 2024

Breckenridge Duloxetine Recall Expands—Now Approximately 70 Million Pills

As The Block Firm previously revealed, Breckenridge Pharmaceutical, Inc. has recalled at least 50 million tablets of Duloxetine due to the presence of nitrosamines, potent…

View Details

June 4, 2024

Court Grants Final Approval to $46.5 Million Class Action Settlement

This month The Block Firm obtained final approval of a $46.5 million class action settlement, which will benefit over a million class members nationwide. The…

View Details

May 30, 2024

The Block Firm Files Class Action About Contaminated Drugs

This week The Block Firm, partnering with our good friends at Anderson & Shah, filed a class action (read complaint here) against the manufacturer of…

View Details

May 21, 2024

Attorney Max Marks Argues on behalf of Fitzgerald Fruit Farms in front of the Supreme Court of Georgia in Case Whitaker Farms LLC vs. Fitzgerald Farms LLC

On May 16, 2024 Max Marks argued on behalf of Fitzgerald Farms in front of the Supreme Court of Georgia, defending his victories at trial and before…

View Details

May 17, 2024

FDA Recalls Duloxetine: The Block Firm continues to investigate

The U.S. Food and Drug Administration (FDA) has recently issued a recall for duloxetine, a medication commonly prescribed for depression and anxiety. If you or…

View Details

May 8, 2024

The Block Firm Investigates the Presence of Carcinogens in Duloxetine (Generic Cymbalta)

Millions of Americans take the drug duloxetine—a generic form of Cymbalta—for depression, pain, and anxiety. According to a recent FDA announcement, tens of millions of…

View Details

March 20, 2024

The Block Firm Investigates Unapproved Thyroid Drug, Adthyza

The Block Firm is investigating a new potential case regarding Adthyza, an unapproved thyroid drug manufactured by Azurity. At The Block Firm, we believe that…

View Details

OUR PEOPLE

We’re here when you need us.

Group 170